198 related articles for article (PubMed ID: 30863062)
1. Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo.
Zhao X; Fan J; Wu P; Wei C; Chen Q; Ming Z; Yan J; Yang L
Int J Nanomedicine; 2019; 14():1299-1309. PubMed ID: 30863062
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel-loaded polymeric nanoparticles combined with chronomodulated chemotherapy on lung cancer: In vitro and in vivo evaluation.
Hu J; Fu S; Peng Q; Han Y; Xie J; Zan N; Chen Y; Fan J
Int J Pharm; 2017 Jan; 516(1-2):313-322. PubMed ID: 27884713
[TBL] [Abstract][Full Text] [Related]
3. Polymeric Nanomedicine for Combined Gene/Chemotherapy Elicits Enhanced Tumor Suppression.
Xu B; Xia S; Wang F; Jin Q; Yu T; He L; Chen Y; Liu Y; Li S; Tan X; Ren K; Yao S; Zeng J; Song X
Mol Pharm; 2016 Feb; 13(2):663-76. PubMed ID: 26695934
[TBL] [Abstract][Full Text] [Related]
4. A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer.
Jiménez-López J; El-Hammadi MM; Ortiz R; Cayero-Otero MD; Cabeza L; Perazzoli G; Martin-Banderas L; Baeyens JM; Prados J; Melguizo C
Pharmacol Res; 2019 Mar; 141():451-465. PubMed ID: 30634051
[TBL] [Abstract][Full Text] [Related]
5. Improving antitumor outcomes for palliative intratumoral injection therapy through lecithin- chitosan nanoparticles loading paclitaxel- cholesterol complex.
Chu XY; Huang W; Wang YL; Meng LW; Chen LQ; Jin MJ; Chen L; Gao CH; Ge C; Gao ZG; Gao CS
Int J Nanomedicine; 2019; 14():689-705. PubMed ID: 30774330
[TBL] [Abstract][Full Text] [Related]
6. Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy.
Zou L; Liu X; Li J; Li W; Zhang L; Fu C; Zhang J; Gu Z
Theranostics; 2021; 11(9):4171-4186. PubMed ID: 33754055
[No Abstract] [Full Text] [Related]
7. Anticancer activity of paclitaxel-loaded keratin nanoparticles in two-dimensional and perfused three-dimensional breast cancer models.
Foglietta F; Spagnoli GC; Muraro MG; Ballestri M; Guerrini A; Ferroni C; Aluigi A; Sotgiu G; Varchi G
Int J Nanomedicine; 2018; 13():4847-4867. PubMed ID: 30214193
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma:
Riestra-Ayora J; Sánchez-Rodríguez C; Palao-Suay R; Yanes-Díaz J; Martín-Hita A; Aguilar MR; Sanz-Fernández R
Drug Deliv; 2021 Dec; 28(1):1376-1388. PubMed ID: 34180747
[TBL] [Abstract][Full Text] [Related]
9. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
[TBL] [Abstract][Full Text] [Related]
10. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
[TBL] [Abstract][Full Text] [Related]
11. p53-dependent apoptosis is essential for the antitumor effect of paclitaxel response to DNA damage in papillary thyroid carcinoma.
Wu W; Wei T; Li Z; Zhu J
Int J Med Sci; 2021; 18(14):3197-3205. PubMed ID: 34400889
[TBL] [Abstract][Full Text] [Related]
12. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL
J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783
[TBL] [Abstract][Full Text] [Related]
13. Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo.
Wang W; Xi M; Duan X; Wang Y; Kong F
Int J Nanomedicine; 2015; 10():3737-50. PubMed ID: 26045664
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo.
Duan XC; Yao X; Zhang S; Xu MQ; Hao YL; Li ZT; Zheng XC; Liu M; Li ZY; Li H; Wang JR; Feng ZH; Zhang X
Int J Nanomedicine; 2019; 14():195-204. PubMed ID: 30636872
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine-based paclitaxel induced apoptotic signaling pathways in A562 leukemia cancer cells.
Wang Y; Zhou L; Xiao M; Sun ZL; Zhang CY
Colloids Surf B Biointerfaces; 2017 Jan; 149():16-22. PubMed ID: 27716527
[TBL] [Abstract][Full Text] [Related]
16. Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo.
Chen S; Zhang Z; Zhang J
Drug Des Devel Ther; 2019; 13():1145-1153. PubMed ID: 31114158
[No Abstract] [Full Text] [Related]
17. Paclitaxel-loaded trimethyl chitosan-based polymeric nanoparticle for the effective treatment of gastroenteric tumors.
Song RF; Li XJ; Cheng XL; Fu AR; Wang YH; Feng YJ; Xiong Y
Oncol Rep; 2014 Oct; 32(4):1481-8. PubMed ID: 25051142
[TBL] [Abstract][Full Text] [Related]
18. Smart Polymeric Nanoparticles with pH-Responsive and PEG-Detachable Properties (II): Co-Delivery of Paclitaxel and VEGF siRNA for Synergistic Breast Cancer Therapy in Mice.
Jin M; Hou Y; Quan X; Chen L; Gao Z; Huang W
Int J Nanomedicine; 2021; 16():5479-5494. PubMed ID: 34413645
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
[TBL] [Abstract][Full Text] [Related]
20. Synergistic Effect of Graphene Oxide Coated Nanotised Apigenin with Paclitaxel (GO-NA/PTX): A ROS Dependent Mitochondrial Mediated Apoptosis in Ovarian Cancer.
Pal MK; Jaiswar SP; Dwivedi A; Goyal S; Dwivedi VN; Pathak AK; Kumar V; Sankhwar PL; Ray RS
Anticancer Agents Med Chem; 2017; 17(12):1721-1732. PubMed ID: 28443516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
